INmune Bio, Inc. (NASDAQ:INMB) Q3 2024 Earnings Call Transcript October 31, 2024
INmune Bio, Inc. misses on earnings expectations. Reported EPS is $-0.6 EPS, expectations were $-0.49.
Operator: Greetings, and welcome to the INmune Bio Third Quarter 2024 Earnings Call. As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call. At this time, it is my pleasure to introduce Mr. David Moss, CFO of INmune Bio. David?
David Moss: Thank you,...
